Evidence for use of fibrates in diabetic dyslipidemia: are we looking hard enough?

Curr Opin Lipidol. 2011 Feb;22(1):76-7. doi: 10.1097/MOL.0b013e328342b0e9.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Diabetes Complications / drug therapy
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / etiology*
  • Fibric Acids / therapeutic use*
  • Humans
  • PPAR alpha / agonists

Substances

  • Fibric Acids
  • PPAR alpha